Literature DB >> 19234142

Essential role of the disintegrin-like domain in ADAMTS13 function.

Rens de Groot1, Ajoy Bardhan, Nalisha Ramroop, David A Lane, James T B Crawley.   

Abstract

ADAMTS13 is a highly specific multidomain plasma metalloprotease that regulates the multimeric size and function of von Willebrand factor (VWF) through cleavage at a single site in the VWF A2 domain. The precise role that the ADAMTS13 disintegrin-like domain plays in its function remains uncertain. Truncated ADAMTS13 variants suggested the importance of the disintegrin-like domain for both enzyme activity and specificity. Targeted mutagenesis of nonconserved regions (among ADAMTS family members) in the disintegrin-like domain identified 3 of 8 ADAMTS13 mutants (R349A, L350G, V352G) with reduced proteolytic activity. Kinetic analyses revealed a 5- to 20-fold reduction in catalytic efficiency of VWF115 (VWF residues 1554-1668) proteolysis by these mutants. These residues form a predicted exposed exosite on the surface of the disintegrin-like domain that lies approximately 26 A from the active site. Kinetic analysis of VWF115 carrying the D1614A mutation suggested that Arg349 in the ADAMTS13 disintegrin-like domain interacts directly with Asp1614 in VWF A2. We hypothesize that this interaction assists in positioning the scissile bond within the active site of ADAMTS13 and therefore plays a major role in determining cleavage parameters (K(m) and k(cat)), as opposed to binding affinity (K(d)) of ADAMTS13 for VWF, the latter being primarily determined by the spacer domain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19234142     DOI: 10.1182/blood-2008-11-187914

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  38 in total

1.  The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.

Authors:  Rens de Groot; David A Lane; James T B Crawley
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

Review 2.  A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms.

Authors:  Suneel S Apte
Journal:  J Biol Chem       Date:  2009-09-04       Impact factor: 5.157

3.  Crystal structures of the noncatalytic domains of ADAMTS13 reveal multiple discontinuous exosites for von Willebrand factor.

Authors:  Masashi Akiyama; Soichi Takeda; Koichi Kokame; Junichi Takagi; Toshiyuki Miyata
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-30       Impact factor: 11.205

4.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

Review 5.  Structure-function and regulation of ADAMTS-13 protease.

Authors:  X L Zheng
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

6.  The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function.

Authors:  Brenda M Luken; Luke Y N Winn; Jonas Emsley; David A Lane; James T B Crawley
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

7.  Rearranging exosites in noncatalytic domains can redirect the substrate specificity of ADAMTS proteases.

Authors:  Weiqiang Gao; Jian Zhu; Lisa A Westfield; Elodee A Tuley; Patricia J Anderson; J Evan Sadler
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

8.  Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain.

Authors:  Wouter Pos; Nicoletta Sorvillo; Rob Fijnheer; Hendrik B Feys; Paul H P Kaijen; Gestur Vidarsson; Jan Voorberg
Journal:  Haematologica       Date:  2011-06-28       Impact factor: 9.941

9.  ADAMTS13, lucky to have a hydrophobic pocket.

Authors:  X Long Zheng
Journal:  Blood       Date:  2015-03-19       Impact factor: 22.113

Review 10.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.